Wednesday, June 10, 2026

Patent intelligence Β· EP

EP 1527086

VERBINDUNGEN DIE P-SELECTIN BINDEN

expired A61K 48/ 00 A IA61K48/00A61P/100A61P/104
Status expired
Pipeline programs 1
Years to expiry 0
Applicant portfolio 10
Patent details β€” EP 1527086
Jurisdiction
EP
Status
expired
Grant date
May 4, 2005
Expiration
Apr 29, 2025
CPC classes
A61K 48/ 00 A I, A61K48/00, A61P/100, A61P/104
View on Google Patents β†—

Quick answer

EP 1527086 (VERBINDUNGEN DIE P-SELECTIN BINDEN) is held by YAMANOUCHI EUROP BV [NL]. Status: expired. Granted May 4, 2005. Expires Apr 29, 2025 (0 years remaining) β€” relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
β€”
CPC classes
A61K 48/ 00 A I, A61K48/00, A61P/100, A61P/104, A61P/1100, A61P/1312

More from YAMANOUCHI EUROP BV [NL]

Related pharmaceutical patents in our USPTO index.

  1. CN 120418289

    Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors

    ASTELLAS PHARMA EUROPE B V Β· Expires Jul 27, 2045

    granted
  2. KR 20240032847

    CLDN18.2 및 CD3에 κ²°ν•©ν•˜λŠ” μ΄μ€‘νŠΉμ΄ κ²°ν•©μ œ

    ASTELLAS PHARMA EUROPE B V [NL] Β· Expires Mar 7, 2044

    granted
  3. CN 105120840

    Composition of tiacumicin compounds

    ASTELLAS PHARMA EUROP B V Β· Expires Nov 27, 2035

    granted
  4. EP 1549658

    VERBINDUNGEN AUF GLUKOSEBASIS MIT AFFINITÜT FÜR P-SELEKTIN

    YAMANOUCHI EUROP BV [NL] Β· Expires Jul 1, 2025

    expired
  5. EP 1423413

    SELEKTIV P-SELECTIN BINDENDE PEPTIDISCHE VERBINDUNGEN

    YAMANOUCHI EUROP BV [NL] Β· Expires May 28, 2024

    expired
  6. EP 1392755

    ZUSAMMENSETZUNGEN ENTHALTEND LIPID-POLYMER KONJUGATE

    YAMANOUCHI EUROP BV [NL] Β· Expires Feb 27, 2024

    expired
  7. IS 5505

    Notkun Ñ blându díóls og alfa-hýdroxýsýru til að meðhândla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju

    ASTELLAS PHARMA EUROP B V [NL] Β· Expires May 18, 2020

    expired

Frequently asked questions

What is US patent 1527086?

EP 1527086 (VERBINDUNGEN DIE P-SELECTIN BINDEN) is held by YAMANOUCHI EUROP BV [NL]. Status: expired. Granted May 4, 2005. Expires Apr 29, 2025 (0 years remaining) β€” relevant for patent-cliff and LOE planning.

Who owns EP 1527086?

YAMANOUCHI EUROP BV [NL] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.

When does EP 1527086 expire?

Our index shows an expiration date of Apr 29, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.